Insight Molecular Diagnostics Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 5, 2026 (10 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 24, 2026 | LUCID CAPITAL MARKETS | initiate | — → Buy | — | 32% |
| Aug 18, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Feb 17, 2026 | Lake Street | maintain | Buy → Buy | $12 | 47% |
| Nov 11, 2025 | Needham | maintain | Buy → Buy | $9 | 50% |
| Aug 18, 2025 | Needham | reiterate | Buy → Buy | $4.25 | 50% |
| May 21, 2025 | Lake Street | maintain | Buy → Buy | $8 | 47% |
| May 13, 2025 | Needham | reiterate | Buy → Buy | $4.25 | 50% |
| Apr 8, 2025 | Needham | reiterate | Buy → Buy | $4.25 | 50% |
| Mar 28, 2025 | Lake Street | initiate | — → Buy | $5 | 47% |
| Mar 26, 2025 | Stephens & Co. | reiterate | Equal-Weight → Equal-Weight | $4 | 54% |
| Mar 25, 2025 | Stephens & Co. | reiterate | Equal-Weight → Equal-Weight | $4 | 54% |
| Mar 25, 2025 | Needham | reiterate | Buy → Buy | $4.25 | 50% |
No cross-platform signals in the last 90 days